Fate Therapeutics

🇺🇸United States
Ownership
-
Employees
220
Market Cap
$408.8M
Website

FT819 in Moderate to Severe Active Systemic Lupus Erythematosus

First Posted Date
2024-03-13
Last Posted Date
2024-08-07
Lead Sponsor
Fate Therapeutics
Target Recruit Count
64
Registration Number
NCT06308978
Locations
🇺🇸

University of Minnesota Medical School, Minneapolis, Minnesota, United States

🇺🇸

University of Nebraska Medical Center, Omaha, Nebraska, United States

FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors

First Posted Date
2024-02-05
Last Posted Date
2024-08-23
Lead Sponsor
Fate Therapeutics
Target Recruit Count
351
Registration Number
NCT06241456
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

🇺🇸

Ohio State University - Comprehensive Cancer Center, Columbus, Ohio, United States

🇺🇸

Yale New Haven Hospital - Yale Cancer Center, New Haven, Connecticut, United States

and more 8 locations

FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)

First Posted Date
2023-07-18
Last Posted Date
2024-07-26
Lead Sponsor
Fate Therapeutics
Target Recruit Count
166
Registration Number
NCT05950334
Locations
🇺🇸

Karmanos Cancer Center, Detroit, Michigan, United States

🇺🇸

University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, United States

🇺🇸

University of Nebraska Medical Center, Omaha, Nebraska, United States

and more 3 locations

FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors

First Posted Date
2022-05-27
Last Posted Date
2023-09-21
Lead Sponsor
Fate Therapeutics
Target Recruit Count
5
Registration Number
NCT05395052
Locations
🇺🇸

Hackensack University Medical Center - John Theurer Cancer Center, Hackensack, New Jersey, United States

🇺🇸

Honor Health Research Institute, Scottsdale, Arizona, United States

🇺🇸

UCLA Division of Hematology-Oncology, Los Angeles, California, United States

and more 2 locations

FT576 in Subjects With Multiple Myeloma

First Posted Date
2022-01-10
Last Posted Date
2024-08-02
Lead Sponsor
Fate Therapeutics
Target Recruit Count
31
Registration Number
NCT05182073
Locations
🇺🇸

Texas Oncology-Medical City Dallas, Dallas, Texas, United States

🇺🇸

Indiana University, Indianapolis, Indiana, United States

🇺🇸

Virginia Oncology Associates, Norfolk, Virginia, United States

and more 11 locations

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

First Posted Date
2021-10-06
Last Posted Date
2023-09-21
Lead Sponsor
Fate Therapeutics
Target Recruit Count
16
Registration Number
NCT05069935
Locations
🇺🇸

NEXT Oncology, San Antonio, Texas, United States

🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

and more 1 locations

FT819 in Subjects With B-cell Malignancies

First Posted Date
2020-11-16
Last Posted Date
2024-08-02
Lead Sponsor
Fate Therapeutics
Target Recruit Count
54
Registration Number
NCT04629729
Locations
🇺🇸

University of Iowa, Iowa City, Iowa, United States

🇺🇸

Stanford Cancer Institute, Palo Alto, California, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 14 locations

FT538 in Subjects With Advanced Hematologic Malignancies

First Posted Date
2020-11-04
Last Posted Date
2023-09-21
Lead Sponsor
Fate Therapeutics
Target Recruit Count
42
Registration Number
NCT04614636
Locations
🇺🇸

Washington University, Saint Louis, Missouri, United States

🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

and more 5 locations

FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

First Posted Date
2020-09-16
Last Posted Date
2023-09-21
Lead Sponsor
Fate Therapeutics
Target Recruit Count
12
Registration Number
NCT04551885
Locations
🇺🇸

University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, United States

🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

🇺🇸

Hackensack University Medical Center/John Theurer Cancer Center, Hackensack, New Jersey, United States

© Copyright 2024. All Rights Reserved by MedPath